Screening for asymptomatic Chlamydia trachomatis infection in adolescent men by examination of voided urine
Detection of Chlamydia trachomatis (CT) in voided urine with enzyme immunoassay (EIA)' 2 opened possibilities for noninvasive screening of asymptomatic infections. Sensitivity and specificity of direct detection of CT with EIA in urine, compared with cultivation from the urethra, was evaluated in several studies and found to be in the range 59-100% and 93-99.3% respectively.34 In our study the sensitivity and specificity of IDEA-III test in urine from asymptomatic men visiting the STD clinic was 75% and 96-8% respectively.5 These data seem to be acceptable46 for routine screening of asymptomatic adolescent men.
We performed a study on 547 asymptomatic military recruits (group A) and on 71 adolescent men (group B) attending the youth consultation centre. The average age was 20.2 and 18.0 years respectively. Through contact tracing of the 14 truly positive recruits 17 female sexual partners were identified and medically examined. Five women had signs of genitourinary infection and were given antibiotic treatment for CT infection without laboratory testing. Urethra and cervical samples from twelve contacts were examined in the laboratory and seven women were found CT infected. Thus the prevalence of laboratory verified CT infection in the contact group was 58.3%.
In group B urine samples were obtained from 71 adolescent asymptomatic men. Thirteen samples were EIA reactive and all of them were also positive in the verification test, (prevalence 18.3%). From 16 identified female sexual contacts twelve partners were found positive (prevalence 75%).
Thus screening of 547 recruits in group A and 71 men in group B detected 21 and 25 CT infected persons respectively.
The sensitivity of IDEIA-III in urine specimens from asymptomatic men was estimated to be 75%; thus after correction the real prevalence numbers of group A and B would be 3.9% and 24-4%. The low prevalence in military recruits may reflect the fact that approximately 50% of them had either not experienced sexual intercourse or indicated contact with only one partner.
High prevalence in group B corresponds with the prevalence of asymptomatic patients attending the STD clinic,5 while in contrast to the recruit group the majority of these men had already begun sexual activity. agreed to participate. Less than 3% of eligible subjects refused to enter the study. The association between the variables considered and HBsAg serological status was estimated with multivariate odds ratios (OR) and their 95% confidence intervals (CI). Included in the regression equations were terms for age, sex, marital status, number of sexual partners, homosexuality in men, intravenous drug use and, in turn, various indicators of STD history or current infection.
HBsAg positivity was found in 42 subjects (7.1%, 95% CI from 5.2 to 9.9) out of the 588 screened. The prevalence of HBsAg positivity increased with age, from 4.9% in subjects aged 24 years or less to 8.6% in those aged 35 years or more. Compared with subjects aged 24 years or less, the estimated OR was 1.3 for those aged 25-34 and 1.9 for those 2 35; the trend in risk was however not statistically significant (table) . Women tended to have a lower prevalence of infection than men (5.3% vs 7.7%), the corresponding OR being 0.4 (95% CI 0-2-0.8). Intravenous drug use was strongly related with the risk of HBsAg positivity: compared with never users, ever users had an estimated OR of positive HBsAg of 4.3 (95% CI 1.9-9.8). The risk of HBsAg positivity increased with the number of reported 
